Medindia

X

Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Wednesday, June 1, 2011 General News J E 4
Advertisement

NEW YORK, June 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

http://www.reportlinker.com/p0240272/Diabetes-Care-Devices-Emerging-Countries-China-India-Brazil-Opportunity-Assessment-Competitive-Landscape-and-Market-Forecasts-to-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices

Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Summary

GlobalData's new report, "Diabetes Care Devices - Emerging Countries Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016" provides key data, information and analysis on the diabetes care devices market in China and India. The report provides market landscape, competitive landscape and market trends information the diabetes care devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key segments covered include Glucose Monitoring and Insulin Delivery.

- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within the diabetes care devices market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market in China and India.

- Design and develop your product development, marketing and sales strategies.

- Exploit M&A opportunities by identifying market players with the most innovative pipeline.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next being thing in the diabetes care devices market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market and the factors shaping it.

1 Table of contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction and Overview 7

2.1 GlobalData Research Guidance 7

3 Disease Overview: Diabetes 8

3.1 Type I Diabetes 8

3.1.1 Introduction 8

3.1.2 Etiology, Disease Symptoms and Risk Factors 8

3.1.3 Pathophysiology 8

3.1.4 Epidemiology 9

3.1.5 Device Based Disease Treatment and Management: Insulin Delivery 10

3.2 Type 2 Diabetes 11

3.2.1 Introduction 11

3.2.2 Etiology, Disease Symptoms and Risk Factors 11

3.2.3 Pathophysiology 12

3.2.4 Epidemiology 13

3.2.5 Device Based Disease Treatment and Management: 13

4 Diabetes Care Devices, Emerging Markets: Market Characterization 15

4.1 Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 – 2009 15

4.2 Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 16

4.3 Diabetes Care Devices, Emerging Markets, Key Company Shares 17

4.4 Diabetes Care Devices, Emerging Markets, Key Market Trends 20

4.4.1 Increased Government Programs for Diabetes Care Awareness 20

4.4.2 Localization of Manufacturing of Diabetes Care Devices by Big Players 20

4.5 Diabetes Care Devices, Emerging Markets, Market Dynamics 21

4.5.1 Market Drivers 21

4.5.2 Market Restraints 21

5 Glucose Monitoring, Emerging Markets: Market Characterization 23

5.1 Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 – 2009 23

5.2 Glucose Monitoring Strips, Emerging Markets, Forecast Revenue ($m), 2009 – 2016 24

5.3 Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 – 2009 25

5.4 Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 26

5.5 Glucose Monitoring, Emerging Markets, Market Dynamics 27

5.5.1 Market Drivers 27

5.5.2 Market Restraints 27

5.6 Glucose Monitoring, Emerging Markets, Key Company Shares 28

5.6.1 Glucose Monitoring, China, Key Company Shares, 2009 28

5.6.2 Glucose Monitoring, India, Key Company Shares, 2009 29

5.6.3 Glucose Monitoring, Brazil, Key Company Shares 2009 30

6 Insulin Delivery, Emerging Markets: Market Characterization 31

6.1 Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 – 2009 31

6.2 Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 32

6.3 Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 – 2009 33

6.4 Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 34

6.5 Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 – 2009 35

6.6 Insulin Pumps, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 36

6.7 Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 – 2009 37

6.8 Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 38

6.9 Insulin Delivery, Emerging Markets, Market Dynamics 39

6.9.1 Market Drivers 39

6.9.2 Market Restraints 39

6.10 Insulin Delivery, Emerging Markets, Key Company Shares, 2009 40

6.10.1 Insulin Delivery, China, Key Company Shares, 2009 40

6.10.2 Insulin Delivery, India, Key Company Shares 2009 41

6.10.3 Insulin Delivery, Brazil, Key Company Shares 2009 42

7 Diabetes Care Devices, Emerging Markets: Key Market Participants 43

7.1 Glucose Monitoring Devices Market 43

7.2 Insulin Delivery Devices Market 43

7.3 Company Profiles 43

7.3.1 F. Hoffmann-La Roche Ltd 43

7.3.2 LifeScan (Johnson & Johnson) 44

7.3.3 Bayer Healthcare 44

7.3.4 Abbott Laboratories 44

7.3.5 Becton, Dickinson and Company 45

7.3.6 Medtronic 45

7.3.7 Novo Nordisk 46

7.3.8 Other Companies 46

8 Appendix 47

8.1 Acronyms 47

8.2 Sources 47

8.3 Database 48

8.4 Research Methodology 48

8.5 Secondary Research 49

8.6 Primary Research 49

8.7 Models 50

8.8 Forecasts 50

8.9 Expert Panels 50

8.10 GlobalData Consulting 51

8.11 Contact Us 51

8.12 Disclaimer 51

1.1 List of Tables

Table 1: Incidence: New Cases of Type 1 Diabetes in Children (under 14 years) 2010 9

Table 2: Epidemiology: Percent of with Diabetes (20-79 years), 2010 (national) 13

Table 3: Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 – 2009 15

Table 4: Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 16

Table 5: Diabetes Care Devices, China, Key Company Revenue ($m), 2009 17

Table 6: Diabetes Care Devices, India, Key Company Revenue ($m), 2009 18

Table 7: Diabetes Care Devices, Brazil, Key Company Revenue ($m), 2009 19

Table 8: Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 – 2009 23

Table 9: Glucose Monitoring Strips, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 24

Table 10: Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 – 2009 25

Table 11: Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 26

Table 12: Glucose Monitoring, China, Key Company Revenue ($m), 2009 28

Table 13: Glucose Monitoring, India, Key Company Revenue ($m), 2009 29

Table 14: Glucose Monitoring, Brazil, Key Company Revenue ($m), 2009 30

Table 15: Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 – 2009 31

Table 16: Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 32

Table 17: Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 – 2009 33

Table 18: Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 34

Table 19: Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 – 2009 35

Table 20: Insulin Pumps, Emerging Markets, Forecasts Revenues ($m), 2009 – 2016 36

Table 21: Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 – 2009 37

Table 22: Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 38

Table 23: Insulin Delivery, China, Key Company Revenue ($m), 2009 40

Table 24: Insulin Delivery, India, Key Company Revenue ($m), 2009 41

Table 25: Insulin Delivery, Brazil, Key Company Revenue ($m), 2009 42

Table 26: F Hoffman-La Roche, Key Marketed Products, Emerging Markets, 2010 43

Table 27: Johnson & Johnson, Key Marketed Products, Emerging Markets, 2010 44

Table 28: Bayer Healthcare, Key Marketed Products, Emerging Markets, 2010 44

Table 29: Abbott Laboratories, Key Marketed Products, Emerging Markets, 2010 44

Table 30: Becton Dickinson & Company, Key Marketed Products, Emerging Markets, 2010 45

Table 31: Medtronic, Key Marketed Products, Emerging Markets, 2010 45

Table 32: NovoNordisk, Key Marketed Products, Emerging Markets, 2010 46

Table 33: Local Diabetes Care Device Companies in China and India 46

1.2 List of Figures

Figure 1: Incidence: New Cases of Type 1 Diabetes in Children (under 14 years) 2010 9

Figure 2: Epidemiology: Percent of with Diabetes (20-79 years), 2010 (national) 13

Figure 3: Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 – 2009 15

Figure 4: Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 16

Figure 5: Diabetes Care Devices, China, Key Company Shares, 2009 17

Figure 6: Diabetes Care Devices, India, Key Company Shares, 2009 18

Figure 7: Diabetes Care Devices, Brazil, Key Company Shares, 2009 19

Figure 8: Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 – 2009 23

Figure 9: Glucose Monitoring Strips, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 24

Figure 10: Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 – 2009 25

Figure 11: Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 26

Figure 12: Glucose Monitoring, China, Key Company Shares, 2009 28

Figure 13: Glucose Monitoring, India, Key Company Shares, 2009 29

Figure 14: Glucose Monitoring, Brazil, Key Company Shares, 2009 30

Figure 15: Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 – 2009 31

Figure 16: Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 32

Figure 17: Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 – 2009 33

Figure 18: Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 34

Figure 19: Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 – 2009 35

Figure 20: Insulin Pumps, Emerging Markets, Forecasts Revenues ($m), 2009 – 2016 36

Figure 21: Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 – 2009 37

Figure 22: Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 38

Figure 23: Insulin Delivery, China, Key Company Shares, 2009 40

Figure 24: Insulin Delivery, India, Key Company Shares, 2009 41

Figure 25: Insulin Delivery, Brazil, Key Company Shares, 2009 42

Figure 26: GlobalData Methodology 49

Companies mentionedF. Hoffmann-La Roche Ltd

LifeScan (Johnson & Johnson)

Bayer Healthcare

Abbott Laboratories

Becton, Dickinson and Company

Medtronic

Novo Nordisk

Hangzhou Yikang Biotech Co., Ltd.

Biocare

Zhejiang Guoguang Biochemistry Co., Ltd.

Nanjing Hospital & Homecare Imp. & Exp. Co., Ltd.

Shenzhen Yidatai Industrial Development Co., Ltd.

Changsha Sinocare Corporation

Pulsatom Healthcare Pvt Ltd

To order this report:

Medical Devices Industry: Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
The Future of European Pharmaceutical Distribution
S
China In Vitro Diagnostics Market Outlook to 2016